Aims. The aim of this study was to determine the rate of indocyanine green (ICG) staining of bone and
Aims. The aim of this study was to identify factors associated with five-year cancer-related mortality in patients with limb and trunk
Aims. Current literature suggests that survival outcomes and local recurrence rates of primary
In our database of 7935 patients referred for investigation of a
Aims. The aim of this study was to evaluate the surgical management and outcome of patients with an acral
Aims. Surgical site infection (SSI) after
Aims. Time to treatment initiation (TTI) is generally defined as the time from the histological diagnosis of malignancy to the initiation of first definitive treatment. There is no consensus on the impact of TTI on the overall survival in patients with a
Aims. Urgent referral to a specialist centre for patients with a
Aims. The modified Glasgow Prognostic Score (mGPS) uses preoperative CRP and albumin to calculate a score from 0 to 2 (2 being associated with poor outcomes). mGPS is validated in multiple carcinomas. To date, its use in
Aims. Patients with
Aims. While a centralized system for the care of patients with a sarcoma has been advocated for decades, regional variations in survival remain unclear. The aim of this study was to investigate regional variations in survival and the impact of national policies in patients with a
Aims. The aims of this study were to evaluate the long-term outcome
of surgery for bone or
We have investigated the oncological outcome of 63 patients with
We investigated whether our policy of routine re-excision of the tumour bed after an unplanned excision of a
We reviewed retrospectively 236 consecutive patients seen in our
We have investigated the significance of the method of treatment on the oncological and functional outcomes and on the complications in 184 patients with
We retrospectively reviewed 71 histopathologically-confirmed bone and
We evaluated the oncological and functional outcome of 27 patients who had limb salvage for a
We evaluated the risk of late relapse and further
outcome in patients with
The aim of this study was to determine whether
the high-sensitivity modified Glasgow prognostic score (Hs-mGPS) could
predict the disease-specific survival and oncological outcome in
adult patients with non-metastatic